List of Tables
Number of Products under Development for Hypertension 20
Number of Products under Development for Hypertension – Comparative Analysis 21
Number of Products under Development for Dyslipidemia 22
Number of Products under Development for Dyslipidemia – Comparative Analysis 23
Number of Products under Development for Thromboembolism 24
Number of Products under Development for Thromboembolism – Comparative Analysis 25
Number of Products under Development for Acute Heart Failure 26
Number of Products under Development for Congestive Heart Failure (Heart Failure) 27
Number of Products under Development for Congestive Heart Failure (Heart Failure) – Comparative Analysis 28
Number of Products under Development for Chronic Heart Failure 29
Number of Products under Development for Chronic Heart Failure – Comparative Analysis 30
Number of Products under Development by Companies, Hypertension 31
Number of Products under Development by Companies, Dyslipidemia 36
Number of Products under Development by Companies, Thromboembolism 39
Number of Products under Development by Companies, Acute Heart Failure 40
Number of Products under Development by Companies, Congestive Heart Failure (Heart Failure) 42
Number of Products under Development by Companies, Chronic Heart Failure 46
Number of Products under Investigation by Universities/Institutes, Hypertension 48
Number of Products under Investigation by Universities/Institutes, Dyslipidemia 49
Number of Products under Investigation by Universities/Institutes, Thromboembolism 50
Number of Products under Investigation by Universities/Institutes, Congestive Heart Failure (Heart Failure) 51
Number of Products under Investigation by Universities/Institutes, Chronic Heart Failure 51
Comparative Analysis by Late Stage Development, Hypertension 52
Comparative Analysis by Clinical Stage Development, Hypertension 53
Comparative Analysis by Early Stage Development, Hypertension 54
Comparative Analysis by Late Stage Development, Dyslipidemia 55
Comparative Analysis by Clinical Stage Development, Dyslipidemia 56
Comparative Analysis by Early Stage Development, Dyslipidemia 57
Comparative Analysis by Unknown Stage Development, Dyslipidemia 58
Comparative Analysis by Late Stage Development, Thromboembolism 58
Comparative Analysis by Clinical Stage Development, Thromboembolism 59
Comparative Analysis by Early Stage Development, Thromboembolism 60
Comparative Analysis by Late Stage Development, Acute Heart Failure 61
Comparative Analysis by Clinical Stage Development, Acute Heart Failure 61
Comparative Analysis by Early Stage Development, Acute Heart Failure 62
Comparative Analysis by Late Stage Development, Congestive Heart Failure (Heart Failure) 62
Comparative Analysis by Clinical Stage Development, Congestive Heart Failure (Heart Failure) 63
Comparative Analysis by Early Stage Development, Congestive Heart Failure (Heart Failure) 64
Comparative Analysis by Unknown Stage Development, Congestive Heart Failure (Heart Failure) 65
Comparative Analysis by Late Stage Development, Chronic Heart Failure 65
Comparative Analysis by Clinical Stage Development, Chronic Heart Failure 66
Comparative Analysis by Early Stage Development, Chronic Heart Failure 67
Products under Development by Companies, Hypertension 68
Products under Development by Companies, Dyslipidemia 75
Products under Development by Companies, Thromboembolism 79
Products under Development by Companies, Acute Heart Failure 79
Products under Development by Companies, Congestive Heart Failure (Heart Failure) 80
Products under Development by Companies, Chronic Heart Failure 85
Products under Investigation by Universities/Institutes, Hypertension 86
Products under Investigation by Universities/Institutes, Dyslipidemia 87
Products under Investigation by Universities/Institutes, Thromboembolism 88
Products under Investigation by Universities/Institutes, Congestive Heart Failure (Heart Failure) 88
Products under Investigation by Universities/Institutes, Chronic Heart Failure 89
Hypertension – Pipeline by A1M Pharma AB 90
Hypertension – Pipeline by AbbVie Inc 90
Hypertension – Pipeline by Actelion Ltd 91
Hypertension – Pipeline by Afferent Pharmaceuticals Inc 91
Hypertension – Pipeline by Alnylam Pharmaceuticals Inc 92
Hypertension – Pipeline by Anacor Pharmaceuticals Inc 93
Hypertension – Pipeline by AnGes MG Inc 94
Hypertension – Pipeline by APT Therapeutics Inc 94
Hypertension – Pipeline by Arena Pharmaceuticals Inc 95
Hypertension – Pipeline by Ascendis Pharma A/S 96
Hypertension – Pipeline by Asklepion Pharmaceuticals LLC 97
Hypertension – Pipeline by AVEO Pharmaceuticals Inc 97
Hypertension – Pipeline by Bayer AG 98
Hypertension – Pipeline by Bial – Portela & Ca SA 98
Hypertension – Pipeline by Biolab Farmaceutica Ltda 99
Hypertension – Pipeline by BioRestorative Therapies Inc 99
Hypertension – Pipeline by Boryung Pharmaceutical Co Ltd 100
Hypertension – Pipeline by Cellceutix Corp 100
Hypertension – Pipeline by Celsion Corp 101
Hypertension – Pipeline by Celtaxsys Inc 101
Hypertension – Pipeline by Chong Kun Dang Pharmaceutical Corp 102
Hypertension – Pipeline by CJ HealthCare Corp 102
Hypertension – Pipeline by Complexa Inc 103
Hypertension – Pipeline by Conatus Pharmaceuticals Inc 103
Hypertension – Pipeline by Corion Biotech Srl 104
Hypertension – Pipeline by Cumberland Pharmaceuticals Inc 104
Hypertension – Pipeline by Cytokinetics Inc 105
Hypertension – Pipeline by Daewoong Pharmaceutical Co Ltd 106
Hypertension – Pipeline by Daiichi Sankyo Company Ltd 107
Hypertension – Pipeline by DiaMedica Inc 107
Hypertension – Pipeline by Eli Lilly and Company 108
Hypertension – Pipeline by Esperion Therapeutics Inc 108
Hypertension – Pipeline by F. Hoffmann-La Roche Ltd 109
Hypertension – Pipeline by Ferring International Center SA 109
Hypertension – Pipeline by Galectin Therapeutics Inc 110
Hypertension – Pipeline by Genextra Spa 110
Hypertension – Pipeline by Gilead Sciences Inc 111
Hypertension – Pipeline by GlaxoSmithKline Plc 112
Hypertension – Pipeline by Glenveigh Medical LLC 112
Hypertension – Pipeline by HanAll Biopharma Co Ltd 113
Hypertension – Pipeline by Hanmi Pharmaceuticals Co Ltd 114
Hypertension – Pipeline by HitGen LTD 114
Hypertension – Pipeline by Innopharmax Inc 115
Hypertension – Pipeline by Insmed Inc 115
Hypertension – Pipeline by INVENT Pharmaceuticals Inc 116
Hypertension – Pipeline by Ionis Pharmaceuticals Inc 116
Hypertension – Pipeline by Ironwood Pharmaceuticals Inc 117
Hypertension – Pipeline by Jeil Pharmaceutical Co Ltd 118
Hypertension – Pipeline by Johnson & Johnson 119
Hypertension – Pipeline by JW Pharmaceutical Corp 120
Hypertension – Pipeline by Kowa Company Ltd 120
Hypertension – Pipeline by Leading BioSciences Inc 121
Hypertension – Pipeline by Lee’s Pharmaceutical Holdings Ltd 121
Hypertension – Pipeline by Les Laboratoires Servier SAS 122
Hypertension – Pipeline by LFB SA 122
Hypertension – Pipeline by LG Life Science LTD 123
Hypertension – Pipeline by LinXis BV 123
Hypertension – Pipeline by Liquidia Technologies Inc 124
Hypertension – Pipeline by Lotus Pharmaceutical Co Ltd 124
Hypertension – Pipeline by MannKind Corp 125
Hypertension – Pipeline by Mast Therapeutics Inc 125
Hypertension – Pipeline by Merck & Co Inc 126
Hypertension – Pipeline by Mezzion Pharma Co Ltd 126
Hypertension – Pipeline by miRagen Therapeutics Inc 127
Hypertension – Pipeline by Mitsubishi Tanabe Pharma Corp 127
Hypertension – Pipeline by Morphogen-IX Ltd 128
Hypertension – Pipeline by Neurim Pharmaceuticals Ltd 128
Hypertension – Pipeline by Nippon Kayaku Co Ltd 129
Hypertension – Pipeline by Nippon Shinyaku Co Ltd 130
Hypertension – Pipeline by Novartis AG 131
Hypertension – Pipeline by Noxamet Ltd 131
Hypertension – Pipeline by Omeros Corp 132
Hypertension – Pipeline by Peloton Therapeutics Inc 132
Hypertension – Pipeline by Pfizer Inc 133
Hypertension – Pipeline by PhaseBio Pharmaceuticals Inc 133
Hypertension – Pipeline by Pluristem Therapeutics Inc 134
Hypertension – Pipeline by Polyphor Ltd 134
Hypertension – Pipeline by Proteo Inc 135
Hypertension – Pipeline by Pulmokine Inc 135
Hypertension – Pipeline by Quantum Genomics SA 136
Hypertension – Pipeline by Reata Pharmaceuticals Inc 136
